Work

Enhancing Cd20.car Nk Cell Therapy in Rituximab-resistant Burkitt Lymphoma Using Il-15-based Immunomodulators With Nktr-255 or Anti-cd16-il15-anti-cd19 Trike

Year: 2025
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4413882592
FWCI:
Cites:
Cited by:
Related to: 10